Ann Oncol

1. RAY-COQUARD I, Cropet C, Harter P, Pujade-Lauraine E, et al
   Reply to Letter to the Editor "Long-term follow-up of PAOLA-1 and the evolving landscape of post-PARP treatment strategies in ovarian cancer" by Arenhardt and Nogueira-Rodrigues.
   Ann Oncol. 2025 Aug 4:S0923-7534(25)00832-4. doi: 10.1016/j.annonc.2025.
   

   >> Share

   
   

   
   Cancer Res

2. ZUO X, Xu J, Yang D, Yang C, et al
   SRSF9 Forms Phase-separated Condensates to Promote Ovarian Cancer Progression by Inducing RNA Alternative Splicing that is Inhibited by m6A Modification.
   Cancer Res. 2025 Aug 7. doi: 10.1158/0008-5472.CAN-24-4233.
   

   >> Share

   
   

   
   Gynecol Oncol

3. BOGANI G, Fagotti A, Chiantera V, De Iaco P, et al
   The role of hyperthermic intraperitoneal chemotherapy (HIPEC) in ovarian cancer.
   Gynecol Oncol. 2025;200:161-168.
   

   >> Share

   
   

   
   PLoS One

4. DURANTE V, Wittwer A, Theek B, Martinez-Osuna M, et al
   Precision-cut tumor tissue slices, a novel tool to study the tumor microenvironment interactions with chimeric antigen receptor (CAR) T cells.
   PLoS One. 2025;20:e0327322.
   

   >> Share

   
   

Free Medical Abstracts
Privacy Policy
Sponsors
Share